<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-29T16:03:50Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/117072" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/117072</identifier><datestamp>2025-03-18T14:15:59Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia</dc:title>
   <dc:creator>Martínez Orgado, José Antonio</dc:creator>
   <dc:creator>Fernádez Frutos, Beatriz</dc:creator>
   <dc:creator>González, Rita</dc:creator>
   <dc:creator>Romero, Eva</dc:creator>
   <dc:creator>Urigüen, Leire</dc:creator>
   <dc:creator>Romero, Julián</dc:creator>
   <dc:creator>Viveros Hernando, María Paz</dc:creator>
   <dc:subject>616-053.31</dc:subject>
   <dc:subject>Cannabinoids</dc:subject>
   <dc:subject>CB receptors</dc:subject>
   <dc:subject>Hypoxia–ischemia</dc:subject>
   <dc:subject>Brain damage</dc:subject>
   <dc:subject>Newborn rats</dc:subject>
   <dc:subject>Ciencias Biomédicas</dc:subject>
   <dc:subject>24 Ciencias de la Vida</dc:subject>
   <dc:description>This study was designed to evaluate the neuroprotective effect of the cannabinoid agonist WIN-55212 after inducing acute severe asphyxia in newborn rats. The left common carotid artery was ligated in anaesthetised 7-day-old Wistar rats, which were then asphyxiated by inhaling 100% nitrogen for 10 min. Pups recovering from asphyxia were s.c. administered vehicle (n=23), WIN-55212 (0.1 mg/kg, n=18), or WIN-55212 plus the CB1 receptor antagonist SR141716 (3 mg/kg, n=10). Pups undergoing a sham operation served as controls (n=12). Coronal sections of the brain were obtained on the 14th day after surgery and observed under light microscope after Nissl or Fluoro-Jade B (FJB) staining, to respectively quantify surviving or degenerating neurones in the CA1 area of the hippocampus and parietal cortex. Acute asphyxia led to early neurone loss amounting to 19% in the hippocampus and 29% in the cortex (both ANOVA P&lt;0.05 vs. control). Delayed neurone loss occurred in the proportions 13% in the hippocampus and 20% in the cortex (both ANOVA P&lt;0.05 vs. control). Neuronal loss was fully prevented by WIN-55212 administration. Co-administration of SR141716 failed to modify the protective effect of WIN-55212 on early neuronal death, but abolished the WIN-55212-induced prevention of delayed neuronal death. We conclude that when administered after acute severe asphyxia in newborn rats, WIN-55212 shows a neuroprotective effect, reducing both early and delayed neurone loss. This effect is achieved through two parallel CB1-dependent and -independent mechanisms.</dc:description>
   <dc:description>Sociedad Española de Neonatología</dc:description>
   <dc:description>Depto. de Salud Pública y Materno - Infantil</dc:description>
   <dc:description>Fac. de Medicina</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2025-01-30T07:30:25Z</dc:date>
   <dc:date>2025-01-30T07:30:25Z</dc:date>
   <dc:date>2003-06-10</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/117072</dc:identifier>
   <dc:identifier>0169-328X</dc:identifier>
   <dc:identifier>10.1016/s0169-328x(03)00163-3.</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>PI021540/02</dc:relation>
   <dc:relation>Martínez-Orgado, J., Fernández-Frutos, B., González, R., Romero, E., Urigüen, L., Romero, J., &amp; Viveros, M. P. (2003). Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia. Brain research. Molecular brain research, 114(2), 132–139. https://doi.org/10.1016/s0169-328x(03)00163-3</dc:relation>
   <dc:rights>restricted access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Elsevier</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>